Gotham Asset Management LLC decreased its position in Maximus, Inc. (NYSE:MMS) by 6.0% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 70,533 shares of the health services provider’s stock after selling 4,531 shares during the quarter. Gotham Asset Management LLC owned approximately 0.11% of Maximus worth $4,417,000 as of its most recent SEC filing.
Several other large investors have also recently added to or reduced their stakes in the company. Janus Henderson Group PLC raised its position in shares of Maximus by 718.8% in the second quarter. Janus Henderson Group PLC now owns 2,211,638 shares of the health services provider’s stock valued at $138,515,000 after purchasing an additional 1,941,521 shares during the period. Shelton Capital Management bought a new position in shares of Maximus in the second quarter valued at approximately $308,000. AHL Partners LLP raised its position in shares of Maximus by 65.9% in the second quarter. AHL Partners LLP now owns 130,646 shares of the health services provider’s stock valued at $8,182,000 after purchasing an additional 51,917 shares during the period. Clinton Group Inc. raised its position in shares of Maximus by 994.6% in the second quarter. Clinton Group Inc. now owns 54,818 shares of the health services provider’s stock valued at $3,433,000 after purchasing an additional 49,810 shares during the period. Finally, HighTower Advisors LLC raised its position in shares of Maximus by 20.7% in the second quarter. HighTower Advisors LLC now owns 8,304 shares of the health services provider’s stock valued at $518,000 after purchasing an additional 1,425 shares during the period. 97.23% of the stock is currently owned by institutional investors.
In other Maximus news, CEO Richard A. Montoni sold 29,203 shares of the stock in a transaction on Thursday, August 17th. The stock was sold at an average price of $60.38, for a total transaction of $1,763,277.14. Following the transaction, the chief executive officer now owns 549,215 shares in the company, valued at approximately $33,161,601.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, President Bruce Caswell sold 8,000 shares of the stock in a transaction on Thursday, July 27th. The stock was sold at an average price of $60.97, for a total value of $487,760.00. Following the transaction, the president now owns 35,904 shares in the company, valued at approximately $2,189,066.88. The disclosure for this sale can be found here. Insiders have sold a total of 152,403 shares of company stock worth $9,414,501 in the last quarter. Company insiders own 3.10% of the company’s stock.
Shares of Maximus, Inc. (NYSE MMS) traded down 0.17% during trading on Thursday, reaching $65.26. 5,327 shares of the company were exchanged. The stock has a market capitalization of $4.23 billion, a price-to-earnings ratio of 20.92 and a beta of 1.36. The company has a 50 day moving average price of $62.92 and a 200-day moving average price of $61.92. Maximus, Inc. has a one year low of $43.69 and a one year high of $66.38.
Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, August 3rd. The health services provider reported $0.79 earnings per share for the quarter, beating analysts’ consensus estimates of $0.76 by $0.03. Maximus had a return on equity of 25.08% and a net margin of 8.43%. The business had revenue of $600.40 million for the quarter, compared to analysts’ expectations of $614.12 million. During the same quarter in the prior year, the business earned $0.79 EPS. The firm’s revenue for the quarter was down 2.7% on a year-over-year basis. Equities analysts predict that Maximus, Inc. will post $3.13 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 30th. Shareholders of record on Wednesday, November 15th will be given a dividend of $0.045 per share. This represents a $0.18 annualized dividend and a yield of 0.28%. Maximus’s payout ratio is 5.73%.
A number of equities analysts have recently commented on the stock. Zacks Investment Research raised shares of Maximus from a “hold” rating to a “buy” rating and set a $73.00 price target on the stock in a research report on Wednesday, October 4th. Canaccord Genuity lowered shares of Maximus from a “buy” rating to a “hold” rating and set a $62.00 price target on the stock. in a research report on Tuesday, July 4th. BidaskClub lowered shares of Maximus from a “strong-buy” rating to a “buy” rating in a research report on Thursday, July 6th. Robert W. Baird reissued a “hold” rating and issued a $64.00 price target on shares of Maximus in a research report on Friday, September 1st. Finally, Maxim Group set a $66.00 price target on shares of Maximus and gave the company a “hold” rating in a research report on Thursday, August 3rd. One equities research analyst has rated the stock with a sell rating and nine have issued a hold rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $63.14.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.